Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,702.00
Ask: 1,703.00
Change: -20.00 (-1.16%)
Spread: 1.00 (0.059%)
Open: 1,729.00
High: 1,729.00
Low: 1,699.00
Prev. Close: 1,725.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 Nov 2013 07:00

RNS Number : 3395T
Smiths Group PLC
19 November 2013
 

 

News Release

London, 19 November 2013

For immediate release

 

 

SMITHS GROUP PLC INTERIM MANAGEMENT STATEMENT

 

Smiths Group Chairman Donald Brydon will make the following Interim Management Statement at the Company's Annual General Meeting in London today.

 

In the three months to 2 November 2013, overall trading at Smiths Group has been in line with expectations. Revenue and headline operating profit have both grown on an underlying and reported basis. Headline operating profit improvements in Detection, John Crane and Flex-Tek more than offset some weakness in Medical and Interconnect. Expectations for the year remain broadly in line with the outlook given at the full year results, although foreign exchange translation is expected to be a headwind at current rates and sales to government-funded customers remain a risk.

 

John Crane delivered modest headline operating profit growth in the first quarter as a result of productivity gains and favourable mix. Revenue was at a similar level to last year with continued growth in aftermarket revenues offsetting weaker sales to first fit OEM customers, reflecting the phasing of certain projects. The order book is ahead of last year with a positive book-to-bill ratio. As a result, John Crane is expected to grow in line with the outlook given at the full year results in September.

 

Smiths Medical saw underlying revenue decline as improved hardware sales were more than offset by a weakness in demand for single-use consumables. As expected, headline operating profit in the first quarter was held back by the impact of the US medical device tax and continued tough trading in developed markets. The full year performance is expected to be below the prior year for the same reasons.

 

Smiths Detection delivered strong underlying revenue and headline operating profit in the first quarter against a weak comparator period. We continue to pursue operational improvements and manufacturing efficiencies. The order book for the full year remains slightly below the equivalent point last year. As a result, we remain cautious about the revenue outlook, but expect productivity initiatives to benefit margins.

 

Smiths Interconnect experienced declines in underlying revenue and headline operating profit against a strong comparator period. Growth in Power was offset by lower revenues in Microwave and Connectors caused by a slowdown in demand from defence customers and on-going weakness in Europe, despite increased sales in the telecommunications market. Looking to the full year, improved trading in some commercial end markets is likely to offset weaker demand in defence, resulting in relatively modest growth overall, with a bias to the second half.

 

Flex-Tek has made good progress growing underlying revenue through a strong performance in US residential construction. Headline operating profit and margins improved as a result of the higher volumes. Despite a demanding comparator period, the outlook for the full year remains positive driven by the aerospace order book and US housing.

 

At 2 November, net debt was £740m, slightly reduced from the £744m at 31 July 2013.

 

ENDS

This press release contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of the press release and the Company undertakes no obligation to update these forward-looking statements. Nothing in this press release should be construed as a profit forecast.

 

 

Investor Relations

Peter Durman: +44 (0)20 7808 5535

 

Media Relations

Colin McSeveny: +44 (0)20 7808 5534

Anthony Cardew - Cardew Group: +44 (0)20 7930 0777

 

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFEDLELTLIV
Date   Source Headline
26th Mar 20217:00 amRNSSmiths Group plc Interim Results 2021
1st Mar 202112:05 pmRNSTotal Voting Rights
3rd Feb 202111:10 amRNSHolding(s) in Company
1st Feb 202112:20 pmRNSTotal Voting Rights
1st Feb 202112:19 pmRNSDirector/PDMR Shareholding
4th Jan 20214:08 pmRNSTotal Voting Rights
23rd Dec 20201:24 pmRNSHolding(s) in Company - Replacement
16th Dec 20205:17 pmRNSHolding(s) in Company
1st Dec 202010:00 amRNSTotal Voting Rights
19th Nov 20209:03 amRNSDirectorate Change
16th Nov 20204:30 pmRNSResult of AGM
16th Nov 20207:00 amRNSSmiths Group Q1 Trading Statement
4th Nov 20204:41 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:36 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:01 amRNSBlock listing Interim Review
2nd Nov 202010:00 amRNSTotal Voting Rights
28th Oct 20204:09 pmRNSDirector/PDMR Shareholding
16th Oct 20205:46 pmRNSDirector/PDMR Shareholding
15th Oct 20205:41 pmRNSDirector/PDMR Shareholding
15th Oct 20208:00 amRNSAnnual Financial Report
1st Oct 202011:00 amRNSTotal Voting Rights
24th Sep 20207:15 amRNSDirectorate Change
24th Sep 20207:00 amRNSSmiths Group plc FY2020 Annual Results
1st Sep 202011:00 amRNSTotal Voting Rights
6th Aug 20202:06 pmRNSDirector/PDMR Shareholding
3rd Aug 20201:06 pmRNSDirector/PDMR Shareholding
31st Jul 20205:00 pmRNSTotal Voting Rights
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20207:00 amRNSTrading update & strategic restructuring
22nd Jun 20209:33 amRNSAdditional Listing
20th May 20209:30 amRNSDirector/PDMR Shareholding
1st May 202011:00 amRNSBlock listing Interim Review
1st May 202010:45 amRNSDirector/PDMR Shareholding
30th Apr 20205:15 pmRNSTotal Voting Rights
30th Apr 20202:30 pmRNSDirector/PDMR Shareholding
27th Apr 20202:56 pmRNSDoc re. Listing Rule 9.2.6E
16th Apr 20204:15 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSInterim Results
31st Mar 20207:00 amRNSTrading Update
27th Mar 20203:47 pmRNSFCA moratorium on publication of results
3rd Feb 20203:57 pmRNSDirector/PDMR Shareholding
31st Jan 20205:00 pmRNSTotal Voting Rights
8th Jan 20204:38 pmRNSDirectorate Change
2nd Jan 20202:30 pmRNSTotal Voting Rights
2nd Dec 20199:00 amRNSTotal Voting Rights
13th Nov 201912:57 pmRNSResult of AGM
13th Nov 20197:00 amRNSSmiths Group FY2020 Q1 Trading Statement
11th Nov 201910:57 amRNSDirector/PDMR Shareholding
4th Nov 20194:45 pmRNSBlock listing Interim Review
1st Nov 201910:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.